Last edition
News about
Amgen Partners with Veeva Systems to Drive Innovation in Clinical Trials
Veeva Systems, a leading provider of cloud-based software, data, and consulting services for the life sciences industry, has announced a strategic collaboration with biotechnology giant Amgen to advance clinical trial innovation.
Bausch Health Expands Dermatology Portfolio with YUN Probiotherapy Launch in Poland
Following its partnership with Belgian biotech company YUN NV last June, Bausch Health has launched the YUN ACN skincare line in Poland, expanding its dermatology portfolio.
Shukra Pharmaceuticals has received a Letter of Award (LoA) from HSCC (India) Ltd. for the supply of medicines and diagnostic kits to Afghanistan.
India's Push for API Self-Reliance Under the PLI Scheme
India’s Production Linked Incentive (PLI) scheme for bulk drugs and key starting materials is transforming the country’s pharmaceutical manufacturing landscape, pushing the sector toward self-reliance.
FDA Approves Eisai and Biogen's At-Home Alzheimer's Injection Leqembi IQLIK
Leqembi IQLIK, delivering a 360 mg dose within 15 seconds, will be available from 6 October, 2025, at a list price of USD 19,500 annually for a pack of pre-filled autoinjectors.
Rotzinger Pharmapack Introduces New Filling and Capping Platform for OTC Products
Rotzinger PharmaPack’s VarioFill brings the capabilities of traditionally large-scale production lines into a compact, modular format.
US FDA Completes Inspection at Aurobindo Pharma's Telangana Unit
The inspection of Aurobindo Pharma’s Apitoria Unit-I facility, conducted from 21-29 August, 2025, concluded with five observations.
Genedata Unveils Integrated Sample Management Module to Streamline Biopharma R&D Workflows
Genedata, a Danaher company, has launched a new Sample Management module within its Biopharma Platform to enable fully integrated, automated, and traceable inventory control for biopharmaceutical R&D.
Foresee Pharmaceuticals has received US FDA approval for CAMCEVI ETM (21 mg) as a treatment for advanced prostate cancer.
Vivanza Biosciences Appoints Sarang Bharatbhai Pathak as Additional Director
As Additional Director, Sarang Bharatbhai Pathak will oversee Vivanza’s comprehensive portfolio encompassing sales and marketing, sourcing, deal negotiation, stakeholder relations, operational oversight, strategic leadership, and risk management.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy